Samiya Hashmi, MD
Hospitalist · Elmhurst, ILNPI 1730337106
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Johnson & Johnson at 37.5% of the total. Reporting peaked in 2022 at $235 and has fallen 73.2% since, to $63 in 2025. Among hospitalist clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $45.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$289
- Boehringer Ingelheim$235
- Abbott$183
- Lilly USA, LLC$45
- Phadia US Inc.$18
What the payments were for
- Food & beverage$771100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $289 |
| Boehringer Ingelheim | 2 | $235 |
| Abbott | 3 | $183 |
| Lilly USA, LLC | 2 | $45 |
| Phadia US Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$235
- XARELTO$229
- CARDIOMEMS$135
How this compares
$771 in reported general payments places this provider in the 90th percentile of 1,328 hospitalist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $619 |
| Atorvastatin Calcium | 20 | $119 |
| Hydralazine Hcl | 12 | $100 |
| Prednisone | 31 | $78 |
| Pantoprazole Sodium | 11 | $69 |
| Metoprolol Succinate | 14 | $51 |
| Metoprolol Tartrate | 12 | $41 |
| ClopidogrelClopidogrel Bisulfate | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Elmhurst
- Odulola OdusanyaLibertyville$544K
- Salih SamoChicago$251K
- Eric GluckChicago$80K
- Jorge Gomez AlarconLake Forest$72K
- Alvin ThomasChicago$28K
- Osman QaiyumMount Vernon$22K
- Wajahat HumayunMaywood$20K
- Gabriel DiazMaywood$18K
- Tasmeen HussainChicago$18K
- Juan Pablo Salazar AdumEvanston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.